On Monday, Lifecore Biomedical Inc (NASDAQ: LFCR) opened lower -9.84% from the last session, before settling in for the closing price of $7.62. Price fluctuations for LFCR have ranged from $3.68 to $8.90 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -16.64% over the last five years. Company’s average yearly earnings per share was noted -383.33% at the time writing. With a float of $32.86 million, this company’s outstanding shares have now reached $36.98 million.
The firm has a total of 524 workers. Let’s measure their productivity. In terms of profitability, gross margin is 34.87%, operating margin of -8.24%, and the pretax margin is -11.4%.
Lifecore Biomedical Inc (LFCR) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Lifecore Biomedical Inc is 11.26%, while institutional ownership is 63.64%. The most recent insider transaction that took place on Nov 20 ’24, was worth 71,691. Before that another transaction happened on Nov 11 ’24, when Company’s Former officer proposed sale 30,990 for $6.64, making the entire transaction worth $205,803.
Lifecore Biomedical Inc (LFCR) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -383.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.00% during the next five years compared to 86.82% growth over the previous five years of trading.
Lifecore Biomedical Inc (NASDAQ: LFCR) Trading Performance Indicators
Check out the current performance indicators for Lifecore Biomedical Inc (LFCR). In the past quarter, the stock posted a quick ratio of 1.21. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.58, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Lifecore Biomedical Inc (LFCR)
Analysing the last 5-days average volume posted by the [Lifecore Biomedical Inc, LFCR], we can find that recorded value of 0.62 million was lower than the volume posted last year of 0.67 million. As of the previous 9 days, the stock’s Stochastic %D was 65.24%. Additionally, its Average True Range was 0.59.
During the past 100 days, Lifecore Biomedical Inc’s (LFCR) raw stochastic average was set at 74.02%, which indicates a significant increase from 54.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 100.81% in the past 14 days, which was higher than the 92.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.93, while its 200-day Moving Average is $5.84. Now, the first resistance to watch is $7.41. This is followed by the second major resistance level at $7.94. The third major resistance level sits at $8.30. If the price goes on to break the first support level at $6.52, it is likely to go to the next support level at $6.16. Should the price break the second support level, the third support level stands at $5.63.
Lifecore Biomedical Inc (NASDAQ: LFCR) Key Stats
There are currently 36,827K shares outstanding in the company with a market cap of 291.03 million. Presently, the company’s annual sales total 128,260 K according to its annual income of 12,010 K. Last quarter, the company’s sales amounted to 24,710 K and its income totaled -16,230 K.
